Kevin E. Weddington

Array ( [id] => 6118565 [patent_doc_number] => 20110076238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE PROCESSES' [patent_app_type] => utility [patent_app_number] => 12/963250 [patent_app_country] => US [patent_app_date] => 2010-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11161 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076238.pdf [firstpage_image] =>[orig_patent_app_number] => 12963250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9323657 [patent_doc_number] => 08658678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-25 [patent_title] => 'Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water' [patent_app_type] => utility [patent_app_number] => 12/928306 [patent_app_country] => US [patent_app_date] => 2010-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3559 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12928306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406463 [patent_doc_number] => 20120238532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'TREATMENT OF HUMAN OSTEOSARCOMA' [patent_app_type] => utility [patent_app_number] => 13/512855 [patent_app_country] => US [patent_app_date] => 2010-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11933 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8653140 [patent_doc_number] => 08372889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Methods for modulating metabolism' [patent_app_type] => utility [patent_app_number] => 12/956576 [patent_app_country] => US [patent_app_date] => 2010-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 14613 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12956576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477857 [patent_doc_number] => 20120277264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'ANTITHROMBOTIC AGENT' [patent_app_type] => utility [patent_app_number] => 13/511693 [patent_app_country] => US [patent_app_date] => 2010-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3112 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5978319 [patent_doc_number] => 20110071222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'POTENTIATORS OF INSULIN SECRETION' [patent_app_type] => utility [patent_app_number] => 12/954364 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3687 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071222.pdf [firstpage_image] =>[orig_patent_app_number] => 12954364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355394 [patent_doc_number] => 08673927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Uses of DPP-IV inhibitors' [patent_app_type] => utility [patent_app_number] => 12/946193 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10247 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12946193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689944 [patent_doc_number] => 08389471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Amino acid composition for improving glucose tolerance' [patent_app_type] => utility [patent_app_number] => 12/942629 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7532 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12942629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8490189 [patent_doc_number] => 20120289596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'Dermatological Compositions Comprising a Fat or Oil of an Essential Fatty Acid Triglyceride' [patent_app_type] => utility [patent_app_number] => 13/512278 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4030 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944832 [patent_doc_number] => 20110105452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Oxidant Scavengers for Treatment of Diabetes or Use in Transplantation or Induction of Immune Tolerance' [patent_app_type] => utility [patent_app_number] => 12/941933 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 11799 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105452.pdf [firstpage_image] =>[orig_patent_app_number] => 12941933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071339 [patent_doc_number] => 20110046190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'COMBINATIONS COMPRISING A SELECTIVE CYCLOOXYGENASE-2 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/938868 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8328 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046190.pdf [firstpage_image] =>[orig_patent_app_number] => 12938868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953960 [patent_doc_number] => 20110034421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT' [patent_app_type] => utility [patent_app_number] => 12/909377 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6701 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034421.pdf [firstpage_image] =>[orig_patent_app_number] => 12909377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033552 [patent_doc_number] => 20110082201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Use of L-Butylphthalide in the Manufacture of Medicaments for Prevention and Treatment of Cerebral Infarct' [patent_app_type] => utility [patent_app_number] => 12/908520 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4495 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082201.pdf [firstpage_image] =>[orig_patent_app_number] => 12908520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713334 [patent_doc_number] => 08399474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Method of restoring the incretin effect' [patent_app_type] => utility [patent_app_number] => 12/906740 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4924 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12906740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807856 [patent_doc_number] => 08445508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Method of restoring the incretin effect' [patent_app_type] => utility [patent_app_number] => 12/906735 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4928 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12906735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144543 [patent_doc_number] => 20110130356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'MORPHINE AND MORPHINE PRECURSORS' [patent_app_type] => utility [patent_app_number] => 12/904373 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 25399 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130356.pdf [firstpage_image] =>[orig_patent_app_number] => 12904373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8749541 [patent_doc_number] => 08415374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => 'Combinations of hepatitis C virus inhibitors' [patent_app_type] => utility [patent_app_number] => 12/899840 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8033 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12899840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199885 [patent_doc_number] => 08187590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Probiotic, lactic acid-producing bacteria and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/897604 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19520 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/187/08187590.pdf [firstpage_image] =>[orig_patent_app_number] => 12897604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382309 [patent_doc_number] => 20120225934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'INCLUSION COMPLEX OF DEOXYPODOPHYLLOTOXIN OF CYCLODEXTRIN, PREPARATION METHOD, USE FOR TREATMENT OF CANCER THEREOF' [patent_app_type] => utility [patent_app_number] => 13/502092 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6357 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6150036 [patent_doc_number] => 20110021631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Method of preparing stabilized pharmaceutical compositions comprising active ingredients susceptible to conversion to alternate polymorph forms' [patent_app_type] => utility [patent_app_number] => 12/878562 [patent_app_country] => US [patent_app_date] => 2010-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5731 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021631.pdf [firstpage_image] =>[orig_patent_app_number] => 12878562 [rel_patent_id] =>[rel_patent_doc_number] =>)